中南药学

[1]Akiyama Y，Sonehara K，Maeda D，et al.Genome-wide association study identifies risk loci within the major histocompatibility complex region for Hunner-type interstitial cystitis[J].Cell Rep Med，2023，4(7)：101114.

[2]Fall M，Nordling J，Cervigni M，et al.Hunner lesion disease differs in diagnosis，treatment and outcome from bladder pain syndrome：an ESSIC working group report[J].Scand J Urol，2020，54(2)：91-98.

[3]Wein AJ.Re：update on the pathophysiology of interstitial cystitis/bladder pain syndrome[J].J Urol，2020，204(3)：625.

[4]Homma Y，Akiyama Y，Kim JH，et al.Definition change and update of clinical guidelines for interstitial cystitis and bladder pain syndrome[J].Low Urin Tract Symptoms，2024，16(5)：e12532.

[5]Homma Y，Akiyama Y，Tomoe H，et al.Clinical guidelines for interstitial cystitis/bladder pain syndrome[J].Int J Urol，2020，27(7)：578-589.

[6]Li J，Yi XY，Ai JZ.Broaden horizons：the advancement of interstitial cystitis/bladder pain syndrome[J].Int J Mol Sci，2022，23(23)：14594.

[7]Offiah I，McMahon SB，O’Reilly BA.Interstitial cystitis/bladder pain syndrome：diagnosis and management[J].Int Urogynecol J，2013，24(8)：1243-1256.

[8]Clemens JQ，Meenan RT，Rosetti MCO，et al.Prevalence and incidence of interstitial cystitis in a managed care population[J].J Urol，2005，173(1)：98-102.

[9]Dinis S，De Oliveira JT，Pinto R，et al.From bladder to systemic syndrome：concept and treatment evolution of interstitial cystitis[J].Int J Womens Health，2015，7：735-744.

[10]Akiyama Y，Maeda D，Katoh H，et al.Molecular taxonomy of interstitial cystitis/bladder pain syndrome based on whole transcriptome profiling by next-generation RNA sequencing of bladder mucosal biopsies[J].J Urol，2019，202(2)：290-300.

[11]Wyndaele JJJ，Riedl C，Taneja R，et al.GAG replenishment therapy for bladder pain syndrome/interstitial cystitis[J].Neurourol Urodyn，2019，38(2)：535-544.

[12]Patnaik SS，Laganà AS，Vitale SG，et al.Etiology，pathophysiology and biomarkers of interstitial cystitisumpainful bladder syndrome[J].Arch Gynecol Obstet，2017，295(6)：1341-1359.

[13]Lazzeri M，Hurle R，Casale P，et al.Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans：an update on the evidence[J].Ther Adv Urol，2016，8(2)：91-99.

[14]Keller JJ，Chen YK，Lin HC.Comorbidities of bladder pain syndrome/interstitial cystitis：a population-based study[J].BJU Int，2012，110(11C)：E903-E909.

[15]Jin XW，Liu BK，Zhang X，et al.Establishment of a novel autoimmune experimental model of bladder pain syndrome/interstitial cystitis in C57BL/6 mice[J].Inflammation，2017，40(3)：861-870.

[16]Peng L，Jin X，Li BY，et al.Integrating single-cell RNA sequencing with spatial transcriptomics reveals immune landscape for interstitial cystitis[J].Signal Transduct Target Ther，2022，7(1)：161.

[17]Su F，Zhang W，Meng LF，et al.Multimodal single-cell analyses outline the immune microenvironment and therapeutic effectors of interstitial cystitis/bladder pain syndrome[J].Adv Sci(Weinh)，2022，9(18)：2106063.

[18]Liu HT，Kuo HC.Biomarkers for patients with interstitial cystitis/bladder pain syndrome[J].Urol Sci，2015，26(4)：225-229.

[19]Jacobs BL，Smaldone MC，Tyagi V，et al.Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients[J].Can J Urol，2010，17(1)：4989-4994.

[20]Parsons CL，Argade S，Evans RJ，et al.Role of urinary cations in the etiology of interstitial cystitis：a multisite study[J].Int J Urol，2020，27(9)：731-735.

[21]Keay SK，Zhang CO.Abnormal Akt signalling in bladder epithelial cell explants from patients with interstitial cystitis/bladder pain syndrome can be induced by antiproliferative factor treatment of normal bladder cells[J].BJU Int，2016，118(1)：161-172.

[22]Mormone E，Cisternino A，Capone L，et al.The model of interstitial cystitis for evaluating new molecular strategies of interstitial regeneration in humans[J].Int J Mol Sci，2024，25(4)：2326.

[23]Wróbel A，Serefko A，Bańczerowska-Górska M，et al.Intravesical administration of blebbistatin prevents cyclophosphamide-induced toxicity of the urinary bladder in female Wistar rats[J].Neurourol Urodyn，2019，38(4)：1044-1052.

[24]Ni B，Chen ZS，Shu L，et al.Nrf2 pathway ameliorates bladder dysfunction in cyclophosphamide-induced cystitis via suppression of oxidative stress[J].Oxid Med Cell Longev，2021：4009308.

[25]Li J，Luo H，Dong XY，et al.Therapeutic effect of urine-derived stem cells for protamine/lipopolysaccharide-induced interstitial cystitis in a rat model[J].Stem Cell Res Ther，2017，8(1)：107.

[26]Mohammad A，Laboulaye MA，Shenhar C，et al.Mechanisms of oxidative stress in interstitial cystitis/bladder pain syndrome[J].Nat Rev Urol，2024，21(7)：433-449.

[27]Windgassen S，McKernan L.Cognition，emotion，and the bladder：psychosocial factors in bladder pain syndrome and interstitial cystitis(BPS/IC)[J].Curr Bladder Dysfunct Rep，2020，15(1)：9-14.

[28]Liu X，Yang Y，Gao Y，et al.Estrogen inhibits bladder overactivity in rats with cyclophosphamide-induced cystitis via downregulating the expression of P2X3 receptors in bladder epithelium cells[J].Neurourol Urodyn，2022，41(1)：174-187.

[29]Hanno PM，Erickson D，Moldwin R，et al.Diagnosis and treatment of interstitial cystitis/bladder pain syndrome：AUA guideline amendment[J].J Urol，2015，193(5)：1545-1553.

[30]Clemens JQ，Erickson DR，Varela NP，et al.Diagnosis and treatment of interstitial cystitis/bladder pain syndrome[J].J Urol，2022，208(1)：34-42.

[31]Van Ophoven A，Pokupic S，Heinecke A，et al.A prospective，randomized，placebo controlled，double-blind study of amitriptyline for the treatment of interstitial cystitis[J].J Urol，2004，172(2)：533-536.

[32]Hertle L，Van Ophoven A.Long-term results of amitriptyline treatment for interstitial cystitis[J].Aktuelle Urol，2010，41(S1)：S61-S65.

[33]Thilagarajah R，Witherow RO，Walker MM.Oral cimetidine gives effective symptom relief in painful bladder disease：a prospective，randomized，double-blind placebo-controlled trial[J].BJU Int，2001，87(3)：207-212.

[34]Pearce WA，Chen R，Jain N.Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium[J].Ophthalmology，2018，125(11)：1793-1802.

[35]Sairanen J，Tammela TL，Leppilahti M，et al.Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis：a randomized comparative study[J].J Urol，2005，174(6)：2235-2238.

[36]Forrest JB，Payne CK，Erickson DR.Cyclosporine A for refractory interstitial cystitis/bladder pain syndrome：experience of 3 tertiary centers[J].J Urol，2012，188(4)：1186-1191.

[37]Palugan L，Cerea M，Cirilli M，et al.Intravesical drug delivery approaches for improved therapy of urinary bladder diseases[J].Int J Pharm X，2021，3：100100.

[38]Perez-Marrero R，Emerson LE，Feltis JT.A controlled study of dimethyl sulfoxide in interstitial cystitis[J].J Urol，1988，140(1)：36-39.

[39]Parsons CL，Housley T，Schmidt JD，et al.Treatment of interstitial cystitis with intravesical heparin[J].Br J Urol，1994，73(5)：504-507.

[40]Nickel JC，Jain P，Shore N，et al.Continuous intravesical lidocaine treatment for interstitial cystitis/bladder pain syndrome：safety and efficacy of a new drug delivery device[J].Sci Transl Med，2012，4(143)：143ra100.

[41]Kocatürk H，Atasoy N，Bedir F，et al.Questionnaire-guided evaluation of the effectiveness of long-term intravesical 0.2% chondroitin sulfate therapy in interstitial cystitis[J].Int Urogynecol J，2021，32(5)：1293-1298.

[42]Giberti C，Gallo F，Cortese P，et al.Combined intravesical sodium hyaluronate/chondroitin sulfate therapy for interstitial cystitis/bladder pain syndrome：a prospective study[J].Ther Adv Urol，2013，5(4)：175-179.

[43]Matsuoka PK，Haddad JM，Pacetta AM，et al.Intravesical treatment of painful bladder syndrome：a systematic review and meta-analysis[J].Int Urogynecol J，2012，23(9)：1147-1153.

[44]Kendall HJ，Schrijvers J，Heesakkers JPFA.Current position of neuromodulation for bladder pain syndrome/interstitial cystitis[J].Curr Opin Urol，2024，34(2)：64-68.

[45]Shin JH，Park JH，Ryu CM，et al.Stem cell therapy for interstitial cystitis/bladder pain syndrome[J].Low Urin Tract Symptoms，2024，16(4)：e12527.

[46]Kuo HC.Intravesical injections of autologous platelet-rich plasma for the treatment of refractory interstitial cystitis[J].Low Urin Tract Symptoms，2023，15(6)：210-215.

[47]Majima T，Tyagi P，Dogishi K，et al.Effect of intravesical liposome-based nerve growth factor antisense therapy on bladder overactivity and nociception in a rat model of cystitis induced by hydrogen peroxide[J].Hum Gene Ther，2017，28(7)：598.

[48]Hung FC，Kuo HC.Liposome-encapsulated botulinum toxin A in treatment of functional bladder disorders[J].Toxins，2022，14(12)：838.

[49]Ma C，Zhong XF，Liu R，et al.Co-delivery of oxaliplatin prodrug liposomes with bacillus calmette-guérin for chemo-immunotherapy of orthotopic bladder cancer[J].J Control Release，2024，365：640-653.

[50]GuhaSarkar S，More P，Banerjee R.Urothelium-adherent，ion-triggered liposome-in-gel system as a platform for intravesical drug delivery[J].J Control Release，2017，245：147-156.

[51]Shawky S，Makled S，Awaad A，et al.Quercetin loaded cationic solid lipid nanoparticles in a mucoadhesive in situ gel-a novel intravesical therapy tackling bladder cancer[J].Pharmaceutics，2022，14(11)：2527.

[52]Qi FG，Bao QQ，Hu P，et al.Mild magnetic hyperthermia-activated immuno-responses for primary bladder cancer therapy[J].Biomaterials，2024，307：122514.

[53]Cai XM，Ruan LF，Wang DQ，et al.Boosting chemotherapy of bladder cancer cells by ferroptosis using intelligent magnetic targeting nanoparticles[J].Colloid Surface B，2024，234：113664.

[54]Ways TMM，Lau WM，Khutoryanskiy VV.Chitosan and its derivatives for application in mucoadhesive drug delivery systems[J].Polymers，2018，10(3)：267.

[55]Kong N，Zhang RN，Wu GW，et al.Intravesical delivery of KDM6A-mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer[J].Proc Natl Acad Sci U S A，2022，119(7)：e2112696119.

[56]Du HF，Yin HY，Qin YH，et al.Subcellular nanobionic liposome with high zeta potential enhances intravesical adhesion and drug delivery[J].ACS Nano，2024，18(4)：3583-3596.

[57]Lin TS，Zhao XZ，Zhang YF，et al.Floating hydrogel with self-generating micro-bubbles for intravesical instillation[J].Materials，2016，9(12)：1005.

[58]Jensen MM，Jia W，Schults AJ，et al.Temperature-responsive silk-elastinlike protein polymer enhancement of intravesical drug delivery of a therapeutic glycosaminoglycan for treatment of interstitial cystitis/painful bladder syndrome[J].Biomaterials，2019，217：119293.

[59]Jing WQ，Chen C，Wang GY，et al.Metabolic modulation of intracellular ammonia via intravesical instillation of nanoporter-encased hydrogel eradicates bladder carcinoma[J].Adv Sci，2023，10(12)：e2206893.

[60]Guo W，Liu HC，Zhang JX，et al.Preparation and characterization of a novel composite acellular matrix/hyaluronic acid thermosensitive hydrogel for interstitial cystitis/bladder pain syndrome[J].J Biomed Mater Res A，2024，112(3)：449-462.

[61]Qiu XF，Cao K，Lin TS，et al.Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation[J].Int J Nanomedicine，2017，12：7365-7374.

[62]Ambrosio L，Argenziano M，Cucci MA，et al.Carbosilane dendrimers loaded with siRNA targeting Nrf2 as a tool to overcome cisplatin chemoresistance in bladder cancer cells[J].Antioxidants(Basel)，2020，9(10)：993.

[63]Simó C，Serra-Casablancas M，Hortelao AC，et al.Urease-powered nanobots for radionuclide bladder cancer therapy[J].Nat Nanotechnol，2024，19(4)：554-564.

[64]Cong ZQ，Tang SS，Xie LM，et al.Magnetic-powered Janus cell robots loaded with oncolytic adenovirus for active and targeted virotherapy of bladder cancer[J].Adv Mater，2022，34(26)：e2201042.

[65]Tang SS，Tang DT，Zhou HH，et al.Bacterial outer membrane vesicle nanorobot[J].Proc Natl Acad Sci U S A，2024，121(30)：e2403460121.

[66]Choi H，Cho SH，Hahn SK.Urease-powered polydopamine nanomotors for intravesical therapy of bladder diseases[J].ACS Nano，2020，14(6)：6683-6692.